CoChat
Sign Up
Cited by 448

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Folate-Targeted Therapies for Cancer

Xia, Wei, Low, Philip S.·2010·Journal of Medicinal Chemistry
DOI 10.1021/jm100509v
Open this paper in CoChat — free account

Abstract

ADVERTISEMENT RETURN TO ISSUEPREVPerspectiveNEXTFolate-Targeted Therapies for CancerWei Xia and Philip S. Low*View Author Information Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907*To whom correspondence should be addressed. Phone: +1-765-494-5273. Fax: +1-765-494-5272. E-mail: [email protected]Cite this: J. Med. Chem. 2010, 53, 19, 6811–6824Publication Date (Web):July 28, 2010Publication History Received26 April 2010Published online28 July 2010Published inissue 14 October 2010https://pubs.acs.org/doi/10.1021/jm100509vhttps://doi.org/10.1021/jm100509vreview-articleACS PublicationsCopyright © 2010 American Chemical SocietyRequest reuse permissionsArticle Views9043Altmetric-Citations391LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the…

Overview

Integrity signals

Registry

Crossref · 10.1021/jm100509v

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 2 references

Research works printed but not linked: 148

  1. Pytel D., 2009, Anti-Cancer Agents Med. Chem., 9, 66, 10.2174/187152009787047752 · DOI
  2. Druker B. J., 1996, Nat. Med., 2, 561, 10.1038/nm0596-561 · DOI
  3. Heath V. L., 2009, Nat. Rev. Clin. Oncol., 6, 395, 10.1038/nrclinonc.2009.52 · DOI
  4. Finn R. S., 2009, Expert Rev. Anticancer Ther., 9, 503, 10.1586/era.09.6 · DOI
  5. Lambert J. M., 2005, Curr. Opin. Pharmacol., 5, 543, 10.1016/j.coph.2005.04.017 · DOI
  6. Rao A. V., 2007, Am. J. Geriatr. Pharmacother., 5, 247, 10.1016/j.amjopharm.2007.09.002 · DOI
  7. Modjtahedi H., 2009, Anti-Cancer Drugs, 20, 851, 10.1097/CAD.0b013e3283330590 · DOI
  8. Garanger E., 2007, Anti-Cancer Agents Med. Chem., 7, 552, 10.2174/187152007781668706 · DOI
  9. Irache J. M., 2008, Expert Opin. Drug Delivery, 5, 703, 10.1517/17425247.5.6.703 · DOI
  10. Gupta Y., 2008, Crit. Rev. Ther. Drug Carrier Syst., 25, 347, 10.1615/CritRevTherDrugCarrierSyst.v25.i4.20 · DOI
  11. Low P. S., 2009, Curr. Opin. Chem. Biol., 13, 256, 10.1016/j.cbpa.2009.03.022 · DOI
  12. Carpenter R. D., 2009, J. Med. Chem., 52, 14, 10.1021/jm800313f · DOI
  13. Kularatne S. A., 2009, Mol. Pharmaceutics, 6, 780, 10.1021/mp900069d · DOI
  14. Sega E. I., 2008, Cancer Metastasis Rev., 27, 655, 10.1007/s10555-008-9155-6 · DOI
  15. Leamon C. P., 2002, Bioconjugate Chem., 13, 1200, 10.1021/bc0200430 · DOI
  16. Thomas M., 2009, Ann. N.Y. Acad. Sci., 1175, 32, 10.1111/j.1749-6632.2009.04977.x · DOI
  17. Low P. S., 2008, Acc. Chem. Res., 41, 120, 10.1021/ar7000815 · DOI
  18. Tranoy-Opalinski I., 2008, Anti-Cancer Agents Med. Chem., 8, 618, 10.2174/187152008785133065 · DOI
  19. Ojima I., 2008, Acc. Chem. Res., 41, 108, 10.1021/ar700093f · DOI
  20. Matherly L. H., 2007, Cancer Metastasis Rev., 26, 111, 10.1007/s10555-007-9046-2 · DOI
  21. Zhao R., 2009, J. Biol. Chem., 284, 4267, 10.1074/jbc.M807665200 · DOI
  22. Parker N., 2005, Anal. Biochem., 338, 284, 10.1016/j.ab.2004.12.026 · DOI
  23. Ross J. F., 1994, Cancer, 73, 2432, 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S · DOI
  24. Kalli K. R., 2008, Gynecol. Oncol., 108, 619, 10.1016/j.ygyno.2007.11.020 · DOI
  25. Nakashima-Matsushita N., 1999, Arthritis Rheum., 42, 1609, 10.1002/1529-0131(199908)42:8<1609::AID-ANR7>3.0.CO;2-L · DOI
  26. van der Heijden J. W., 2009, Arthritis Rheum., 60, 12, 10.1002/art.24219 · DOI
  27. Xia W., 2009, Blood, 113, 438, 10.1182/blood-2008-04-150789 · DOI
  28. Turk M. J., 2002, Arthritis Rheum., 46, 1947, 10.1002/art.10405 · DOI
  29. Elnakat H., 2004, Adv. Drug Delivery Rev., 56, 1067, 10.1016/j.addr.2004.01.001 · DOI
  30. Kamen B. A., 2004, Adv. Drug Delivery Rev., 56, 1085, 10.1016/j.addr.2004.01.002 · DOI
  31. Yang J., 2006, Proc. Natl. Acad. Sci. U.S.A., 103, 13872, 10.1073/pnas.0601455103 · DOI
  32. Paulos C. M., 2004, Adv. Drug Delivery Rev., 56, 1205, 10.1016/j.addr.2004.01.012 · DOI
  33. Leamon C. P., 2008, Vitam. Horm., 79, 203, 10.1016/S0083-6729(08)00407-X · DOI
  34. Sandoval R. M., 2004, Am. J. Physiol.: Cell Physiol., 287, C517, 10.1152/ajpcell.00006.2004 · DOI
  35. Li J., 2009, J. Clin. Pharmacol., 49, 1467, 10.1177/0091270009339740 · DOI
  36. Sausville E. A., 2007, ASCO Annual Meeting Proceedings, 2007, 2577
  37. Chancy C. D., 2000, J. Biol. Chem., 275, 20676, 10.1074/jbc.M002328200 · DOI
  38. Mantovani L. T., 1994, Eur. J. Cancer., 30, 363, 10.1016/0959-8049(94)90257-7 · DOI
  39. Leamon C. P., 2007, Int. J. Cancer, 121, 1585, 10.1002/ijc.22853 · DOI
  40. Leamon C. P., 2007, Mol. Pharmaceutics, 4, 659, 10.1021/mp070049c · DOI
  41. Lu Y., 2002, Cancer Immunol. Immunother., 51, 153, 10.1007/s00262-002-0266-6 · DOI
  42. Wang S., 1997, Bioconjugate Chem., 8, 673, 10.1021/bc9701297 · DOI
  43. Leamon C. P., 1993, J. Biol. Chem., 268, 24847, 10.1016/S0021-9258(19)74542-6 · DOI
  44. Leamon C. P., 1992, J. Biol. Chem., 267, 24966, 10.1016/S0021-9258(19)73992-1 · DOI
  45. Mayor S., 1998, EMBO J., 17, 4626, 10.1093/emboj/17.16.4626 · DOI
  46. Kamen B. A., 1986, Proc. Natl. Acad. Sci. U.S.A., 83, 5983, 10.1073/pnas.83.16.5983 · DOI
  47. Ladino C. A., 1997, Int. J. Cancer, 73, 859, 10.1002/(SICI)1097-0215(19971210)73:6<859::AID-IJC16>3.0.CO;2-# · DOI
  48. Lee R. J., 1996, Biochim. Biophys. Acta, 1312, 237, 10.1016/0167-4889(96)00041-9 · DOI
  49. Lee J. W., 2002, Bioorg. Med. Chem., 10, 2397, 10.1016/S0968-0896(02)00019-6 · DOI
  50. Yang J., 2007, J. Pharmacol. Exp. Ther., 321, 462, 10.1124/jpet.106.117648 · DOI
  51. Leamon C. P., 2006, Bioconjugate Chem., 17, 1226, 10.1021/bc060145g · DOI
  52. Reddy J. A., 2007, Cancer Res., 67, 4434, 10.1158/0008-5472.CAN-07-0033 · DOI
  53. Vlashi E., 2009, Mol. Pharmaceutics, 6, 1868, 10.1021/mp900158d · DOI
  54. Wang S., 1996, Bioconjugate Chem., 7, 56, 10.1021/bc9500709 · DOI
  55. Reddy J. A., 2007, Cancer Res., 67, 6376, 10.1158/0008-5472.CAN-06-3894 · DOI
  56. Leamon C. P., 2008, Cancer Res., 68, 9839, 10.1158/0008-5472.CAN-08-2341 · DOI
  57. Leamon C. P., 2005, Bioconjugate Chem., 16, 803, 10.1021/bc049709b · DOI
  58. Henne W. A., 2006, Bioorg. Med. Chem. Lett., 16, 5350, 10.1016/j.bmcl.2006.07.076 · DOI
  59. Crippa F., 1995, Eur. J. Cancer, 31, 686, 10.1016/0959-8049(94)00454-D · DOI
  60. Canevari S., 1995, J. Natl. Cancer. Inst., 87, 1463, 10.1093/jnci/87.19.1463 · DOI
  61. Melani C., 1998, Cancer Res., 58, 4146
  62. Spannuth W. A., 2010, Expert Opin. Biol. Ther., 10, 431, 10.1517/14712591003592069 · DOI
  63. Kranz D. M., 1995, Proc. Natl. Acad. Sci. U.S.A., 92, 9057, 10.1073/pnas.92.20.9057 · DOI
  64. Cho B. K., 1997, Bioconjugate Chem., 8, 338, 10.1021/bc9700244 · DOI
  65. Rund L. A., 1999, Int. J. Cancer, 83, 141, 10.1002/(SICI)1097-0215(19990924)83:1<141::AID-IJC24>3.0.CO;2-0 · DOI
  66. Knutson K. L., 2006, J. Clin. Oncol., 24, 4254, 10.1200/JCO.2006.05.9311 · DOI
  67. Lu Y., 2003, J. Controlled Release, 91, 17, 10.1016/S0168-3659(03)00215-3 · DOI
  68. Yi Y. S., 2009, Mol. Pharmaceutics, 6, 1228, 10.1021/mp900070b · DOI
  69. Miotti S., 1987, Int. J. Cancer, 39, 297, 10.1002/ijc.2910390306 · DOI
  70. Coney L. R., 1991, Cancer Res., 51, 6125
  71. Smith-Jones P. M., 2008, Nucl. Med. Biol., 35, 343, 10.1016/j.nucmedbio.2007.12.008 · DOI
  72. Coney L. R., 1994, Cancer Res., 54, 2448
  73. Figini M., 1994, J. Mol. Biol., 239, 68, 10.1006/jmbi.1994.1351 · DOI
  74. Figini M., 2009, Cancer Immunol. Immunother., 58, 531, 10.1007/s00262-008-0575-5 · DOI
  75. Lu Y., 2005, Int. J. Cancer, 116, 710, 10.1002/ijc.21126 · DOI
  76. Douglas J. T., 1996, Nat. Biotechnol., 14, 1574, 10.1038/nbt1196-1574 · DOI
  77. El-Aneed A., 2004, J. Controlled Release, 94, 1, 10.1016/j.jconrel.2003.09.013 · DOI
  78. Gottschalk S., 1994, Gene Ther., 1, 185
  79. Reddy J. A., 1999, J. Pharm. Sci., 88, 1112, 10.1021/js990169e · DOI
  80. Reddy J. A., 2000, J. Controlled Release, 64, 27, 10.1016/S0168-3659(99)00135-2 · DOI
  81. Lungwitz U., 2005, Eur. J. Pharm. Biopharm., 60, 247, 10.1016/j.ejpb.2004.11.011 · DOI
  82. Benns J. M., 2001, J. Drug Targeting, 9, 123, 10.3109/10611860108997923 · DOI
  83. Hofland H. E., 2002, Mol. Ther., 5, 739, 10.1006/mthe.2002.0604 · DOI
  84. Reddy J. A., 2002, Gene Ther., 9, 1542, 10.1038/sj.gt.3301833 · DOI
  85. Bruckheimer E., 2004, Cancer Gene Ther., 11, 128, 10.1038/sj.cgt.7700662 · DOI
  86. Robbins M., 2009, Oligonucleotides, 19, 89, 10.1089/oli.2009.0180 · DOI
  87. Behlke M. A., 2006, Mol. Ther., 13, 644, 10.1016/j.ymthe.2006.01.001 · DOI · Paper page
  88. Yu B., 2009, AAPS J., 11, 195, 10.1208/s12248-009-9096-1 · DOI
  89. Pirollo K. F., 2008, Cancer Res., 68, 1247, 10.1158/0008-5472.CAN-07-5810 · DOI · Paper page
  90. Dominska M., 2010, J. Cell Sci., 123, 1183, 10.1242/jcs.066399 · DOI
  91. Zhang K., 2008, RNA, 14, 577, 10.1261/rna.739308 · DOI
  92. Citro G., 1994, Br. J. Cancer., 69, 463, 10.1038/bjc.1994.84 · DOI
  93. Kim S. H., 2005, J. Controlled Release, 104, 223, 10.1016/j.jconrel.2005.02.006 · DOI
  94. York A. W., 2009, Biomacromolecules, 10, 936, 10.1021/bm8014768 · DOI
  95. Wang S., 1995, Proc. Natl. Acad. Sci. U.S.A., 92, 3318, 10.1073/pnas.92.8.3318 · DOI
  96. Rait A. S., 2002, Mol. Med., 8, 475, 10.1007/BF03402027 · DOI
  97. Leamon C. P., 2003, Bioconjugate Chem., 14, 738, 10.1021/bc020089t · DOI
  98. Yoshizawa T., 2008, Eur. J. Pharm. Biopharm., 70, 718, 10.1016/j.ejpb.2008.06.026 · DOI
  99. Jeong J. H., 2005, J. Biomater. Sci., Polym. Ed., 16, 1409, 10.1163/156856205774472335 · DOI
  100. van Vlerken L. E., 2006, Expert Opin. Drug Delivery, 3, 205, 10.1517/17425247.3.2.205 · DOI
  101. Hobbs S. K., 1998, Proc. Natl. Acad. Sci. U.S.A., 95, 4607, 10.1073/pnas.95.8.4607 · DOI · Paper page
  102. Immordino M. L., 2006, Int. J. Nanomed., 1, 297, 10.2217/17435889.1.3.297 · DOI · Paper page
  103. Lee R. J., 1995, Biochim. Biophys. Acta, 1233, 134, 10.1016/0005-2736(94)00235-H · DOI
  104. Anderson K. E., 2001, Pharm. Res., 18, 316, 10.1023/A:1011002913601 · DOI
  105. Pan X. Q., 2002, Blood, 100, 594, 10.1182/blood.V100.2.594 · DOI
  106. Gabizon A., 2004, Adv. Drug Delivery Rev., 56, 1177, 10.1016/j.addr.2004.01.011 · DOI
  107. Gabizon A., 2003, Clin. Cancer Res., 9, 6551
  108. Ni S., 2002, Anticancer Res., 22, 2131
  109. Saul J. M., 2003, J. Controlled Release, 92, 49, 10.1016/S0168-3659(03)00295-5 · DOI
  110. Shi G., 2002, J. Controlled Release, 80, 309, 10.1016/S0168-3659(02)00017-2 · DOI
  111. Pan X. Q., 2002, Anticancer Res., 22, 1629
  112. Stephenson S. M., 2003, Anticancer Res., 23, 3341
  113. Thirumamagal B. T., 2006, Bioconjugate Chem., 17, 1141, 10.1021/bc060075d · DOI
  114. Henriksen G., 2004, Nucl. Med. Biol., 31, 441, 10.1016/j.nucmedbio.2003.11.004 · DOI
  115. Lee R. J., 1994, J. Biol. Chem., 269, 3198, 10.1016/S0021-9258(17)41848-5 · DOI
  116. Gabizon A., 1999, Bioconjugate Chem., 10, 289, 10.1021/bc9801124 · DOI
  117. Yamada A., 2008, Clin. Cancer. Res., 14, 8161, 10.1158/1078-0432.CCR-08-0159 · DOI
  118. Zhao X. B., 2007, J. Pharm. Sci., 96, 2424, 10.1002/jps.20885 · DOI
  119. Xiang G., 2008, Int. J. Pharm., 356, 29, 10.1016/j.ijpharm.2007.12.030 · DOI
  120. Vogel K., 1996, J. Am. Chem. Soc., 118, 1581, 10.1021/ja952725m · DOI
  121. Turk M. J., 2002, Biochim. Biophys. Acta, 1559, 56, 10.1016/S0005-2736(01)00441-2 · DOI
  122. Rui Y., 1998, J. Am. Chem. Soc., 120, 11213, 10.1021/ja9742949 · DOI
  123. Sudimack J. J., 2002, Biochim. Biophys. Acta, 1564, 31, 10.1016/S0005-2736(02)00399-1 · DOI
  124. Yokoyama M., 1992, Bioconjugate Chem., 3, 295, 10.1021/bc00016a007 · DOI
  125. Yoo H. S., 2002, J. Controlled Release, 82, 17, 10.1016/S0168-3659(02)00088-3 · DOI
  126. Kwon G. S., 1999, Pharm. Res., 16, 597, 10.1023/A:1011991617857 · DOI
  127. Lee E. S., 2003, J. Controlled Release, 91, 103, 10.1016/S0168-3659(03)00239-6 · DOI
  128. Lee E. S., 2005, J. Controlled Release, 103, 405, 10.1016/j.jconrel.2004.12.018 · DOI
  129. Chen H., 2008, Langmuir, 24, 5213, 10.1021/la703570m · DOI · Paper page
  130. Konda S. D., 2002, Invest. Radiol., 37, 199, 10.1097/00004424-200204000-00005 · DOI
  131. Quintana A., 2002, Pharm. Res., 19, 1310, 10.1023/A:1020398624602 · DOI
  132. Kukowska-Latallo J. F., 2005, Cancer Res., 65, 5317, 10.1158/0008-5472.CAN-04-3921 · DOI
  133. Patri A. K., 2005, Adv. Drug Delivery Rev., 57, 2203, 10.1016/j.addr.2005.09.014 · DOI · Paper page
  134. Sonvico F., 2005, Bioconjugate Chem., 16, 1181, 10.1021/bc050050z · DOI
  135. Kohler N., 2005, Langmuir, 21, 8858, 10.1021/la0503451 · DOI
  136. Tong L., 2007, Adv. Mater., 19, 3136, 10.1002/adma.200701974 · DOI
  137. Huff T. B., 2007, Nanomedicine, 2, 125, 10.2217/17435889.2.1.125 · DOI
  138. Zhang J., 2008, Acta Biomater., 4, 40, 10.1016/j.actbio.2007.06.006 · DOI
  139. Kam N. W., 2005, Proc. Natl. Acad. Sci. U.S.A., 102, 11600, 10.1073/pnas.0502680102 · DOI
  140. Zhou F., 2009, J. Biomed. Opt., 14, 021009, 10.1117/1.3078803 · DOI
  141. Zheng G., 2005, Proc. Natl. Acad. Sci. U.S.A., 102, 17757, 10.1073/pnas.0508677102 · DOI
  142. Glickson J. D., 2008, Mol. Imaging, 7, 101
  143. Nayak S., 2004, J. Am. Chem. Soc., 126, 10258, 10.1021/ja0474143 · DOI
  144. Zhang L., 2004, Int. J. Pharm., 287, 155, 10.1016/j.ijpharm.2004.08.015 · DOI
  145. Ren Y., 2007, Bioconjugate Chem., 18, 836, 10.1021/bc060361p · DOI
  146. Destito G., 2007, Chem. Biol., 14, 1152, 10.1016/j.chembiol.2007.08.015 · DOI
  147. Liu S. Q., 2007, Biomaterials, 28, 1423, 10.1016/j.biomaterials.2006.11.013 · DOI
  148. Perentes J. Y., 2009, Nat. Methods, 6, 143, 10.1038/nmeth.1295 · DOI

Cited by

Sorted by citations

See all 448

Metadata

Authors
Xia, W., & Low, P. S.
Affiliations
Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907
Venue
Journal of Medicinal Chemistry
Publisher
American Chemical Society (ACS)
Published
2010-07-28
Volume
53
Issue
19
Pages
6811-6824
ISSN
  • 0022-2623
  • 1520-4804
DOI
10.1021/jm100509v
Cited by
448
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review